Publications

Export 19 results:
Author [ Title(Asc)] Type Year
Filters: Author is Caravaggio, Fernando  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Β
Chung JKu, Nakajima S, Plitman E, Iwata Y, Uy D, Gerretsen P, Caravaggio F, M Chakravarty M, Graff-Guerrero A.  2016.  Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review.. Am J Geriatr Psychiatry. 24(10):923-39.
T
Caravaggio F, Plavén-Sigray P, Matheson GJames, Plitman E, M Chakravarty M, Borg J, Graff-Guerrero A, Cervenka S.  2018.  Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men.. PLoS One. 13(12):e0209584.
Caravaggio F, Plitman E, Chung JKu, Gerretsen P, Kim J, Iwata Y, M Chakravarty M, Remington G, Graff-Guerrero A.  2017.  Trait impulsiveness is related to smaller post-commissural putamen volumes in males but not females.. Eur J Neurosci. 46(7):2253-2264.
S
Plitman E, Chavez S, Nakajima S, Iwata Y, Chung JKu, Caravaggio F, Kim J, Alshehri Y, M Chakravarty M, De Luca V et al..  2018.  Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.. Psychiatry Res Neuroimaging. 273:16-24.
R
Caravaggio F, Chung JKu, Plitman E, Boileau I, Gerretsen P, Kim J, Iwata Y, Patel R, M Chakravarty M, Remington G et al..  2017.  The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [(11) C]-raclopride and [(11) C]-(+)-PHNO PET.. Hum Brain Mapp. 38(11):5519-5534.
N
Kim J, Plitman E, Iwata Y, Nakajima S, Mar W, Patel R, Chavez S, Chung JKu, Caravaggio F, M Chakravarty M et al..  2019.  Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disorders.. Prog Neuropsychopharmacol Biol Psychiatry. :109839.
L
Chung JKu, Plitman E, Nakajima S, Chow TW, M Chakravarty M, Caravaggio F, Gerretsen P, Brown EE, Iwata Y, Mulsant BH et al..  2016.  Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.. J Alzheimers Dis. 49(4):1189-90.
Chung JKu, Plitman E, Nakajima S, Chow TW, M Chakravarty M, Caravaggio F, Gerretsen P, Brown EE, Iwata Y, Mulsant BH et al..  2015.  Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.. J Alzheimers Dis. 45(3):907-19.
K
Plitman E, Iwata Y, Caravaggio F, Nakajima S, Chung JKu, Gerretsen P, Kim J, Takeuchi H, M Chakravarty M, Remington G et al..  2017.  Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.. Schizophr Bull.
I
Caravaggio F, Gerretsen P, Mar W, Chung JKu, Plitman E, Nakajima S, Kim J, Iwata Y, Patel R, M Chakravarty M et al..  2017.  Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning.. Psychoneuroendocrinology. 81:80-87.
H
Chung JKu, Plitman E, Nakajima S, Caravaggio F, Iwata Y, Gerretsen P, Kim J, Takeuchi H, Shinagawa S, Patel R et al..  2017.  Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.. J Alzheimers Dis. 58(3):747-762.
G
Shah P, Plitman E, Iwata Y, Kim J, Nakajima S, Chan N, Brown EE, Caravaggio F, Torres E, Hahn M et al..  2020.  Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicity.. J Psychiatr Res. 124:151-158.
Plitman E, Nakajima S, de la Fuente-Sandoval C, Gerretsen P, M Chakravarty M, Kobylianskii J, Chung JKu, Caravaggio F, Iwata Y, Remington G et al..  2014.  Glutamate-mediated excitotoxicity in schizophrenia: a review.. Eur Neuropsychopharmacol. 24(10):1591-605.
E
Chung JKu, Plitman E, Nakajima S, Caravaggio F, Shinagawa S, Iwata Y, Gerretsen P, Kim J, Takeuchi H, Patel R et al..  2017.  The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.. J Alzheimers Dis. 60(2):341-347.
D
Chung JKu, Plitman E, Nakajima S, M Chakravarty M, Caravaggio F, Takeuchi H, Gerretsen P, Iwata Y, Patel R, Mulsant BH et al..  2016.  Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.. J Alzheimers Dis. 49(3):743-54.
C
Chung JKu, Plitman E, Nakajima S, M Chakravarty M, Caravaggio F, Gerretsen P, Iwata Y, Graff-Guerrero A.  2016.  Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.. J Geriatr Psychiatry Neurol. 29(3):149-59.
B
Chung JKu, Nakajima S, Shinagawa S, Plitman E, M Chakravarty M, Iwata Y, Caravaggio F, Pollock BG, Gerretsen P, Graff-Guerrero A.  2016.  Benzodiazepine Use Attenuates Cortical β-Amyloid and is Not Associated with Progressive Cognitive Decline in Nondemented Elderly Adults: A Pilot Study Using F(18)-Florbetapir Positron Emission Tomography.. Am J Geriatr Psychiatry. 24(11):1028-1039.
A
Burrer A, Caravaggio F, Manoliu A, Plitman E, Gütter K, Habermeyer B, Stämpfli P, Abivardi A, Schmidt A, Borgwardt S et al..  2020.  Apathy is not associated with reduced ventral striatal volume in patients with schizophrenia.. Schizophr Res.
Caravaggio F, Fervaha G, Iwata Y, Plitman E, Chung JKu, Nakajima S, Mar W, Gerretsen P, Kim J, M Chakravarty M et al..  2018.  Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia.. Int J Geriatr Psychiatry. 33(3):523-530.